Concepedia

Bruce J. Melancon

BJ

Statistics

Publications

29

Citations

2.2K

H-Index

22

Active since

2002

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

AstraZeneca (United States)

John F. Kennedy Center for the Performing Arts

University of Notre Dame

Bruce J. Melancon is an author at Vanderbilt University specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2002–2024

29

Publications

29

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α

Curtis A. Thorne, Alison Hanson, Judsen Schneider et al. · Nature Chemical Biology · 2010 · 487 citations · Full text

, , +12

Structural insights into HDAC6 tubulin deacetylation and its selective inhibition

Y. Miyake, J.J. Keusch, Longlong Wang et al. · Nature Chemical Biology · 2016 · 297 citations · Full text

, , +9

Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery

Bruce J. Melancon, Corey R. Hopkins, Michael R. Wood et al. · Journal of Medicinal Chemistry · 2011 · 223 citations · Full text

, , +17

Selective Activation of M<sub>4</sub>Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

Michael Bubser, Thomas M. Bridges, Ditte Dencker et al. · ACS Chemical Neuroscience · 2014 · 155 citations · Full text

, , +17

Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100

Nellie Byun, Michael Grannan, Michael Bubser et al. · Neuropsychopharmacology · 2014 · 122 citations · Full text

, , +12

1–5 of 29